News
IDIBELL licenses to Janus a patent for the treatment of immune diseases
The Bellvitge Biomedical Research Institute (IDIBELL) has signed a licensing agreement with the company Janus Developments of a patent for an immunomodulatory product for treating immune diseases such as autoimmune diseases, sepsis, hypersensitivity disorders (including, allergic reactions) or post-transplant rejection. The patent has been developed by the researcher of the Human Molecular Genetics group Josep […]
The best experts in the world in personalized cancer medicine meet in L’Hospitalet
On 3 and 4 December the Convention Center of Hesperia L’Hospitalet will hold the IDIBELL Cancer Conference on Personalized Cancer Medicine. The conference will bring together a hundred of researchers around the world. The purpose of the meeting is to highlight recent advances in the biology and natural history of cancer provides new targets for […]
Manel Esteller, ”if the alphabet is genetics, spelling is epigenetics”
Why don’t identical twins have the same disease at the same time? Why do two cats who share the same DNA have different spots? Why do teenagers have mood changes? The answer is in epigenetics, the discipline that deals with the genetic regulatory mechanisms that do not involve changes in the DNA sequence. The director […]
Enrique de Álava: “We are trying to use a combine therapy for Ewing sarcoma”
The conference “Search, validation and clinical translation of new therapeutic targets in Ewing sarcoma found by integrative genomic analyses” by Enrique de Álava, researcher at the Cancer Research Centre (CIC), at the Hospital University of Salamanca and the Spanish High Research Council (CSIC), takes place last 9th November in IDIBELL. “To try to translate into […]
IDIBELL wins the Antonio Baró prize for its commitment to the prevention of occupational hazards
IDIBELL has been awarded with the 2012 Antonio Baró prize for prevention of occupational hazards. The award is given by MC Mutual to companies of Spain. The award recognizes the work of companies making effective policies for the prevention of occupational hazards and demonstrating a commitment to continuous improvement of the working conditions of its […]
Manel Esteller participates in a Royal Society meeting
The Royal Society will host the first scientific meeting between Spain and the United Kingdom, with the title “Networking Nations: Scientific opportunities in the UK and Spain”, on 28 November. This meeting will contribute to the implementation of the Society’s strategic objective to foster international cooperation by strengthening its links with European academies, funders, and […]
Coffee Science with Luis Fuentemilla: ”Forgotten is the limit of our memory”
The coffee science “Speaking about memory” with Dr. Luis Fuentemilla, IDIBELL and UB researcher, at the Can Deu Civic Centre at Les Corts last November 22th, takes part of the Science Week. The event, organized by Les Corts District and the Catalan Association of Scientific Communication (ACCC) with the support of IDIBELL, was about memory […]
A study comparing the epigenome of centenarians and newborns, awarded by Diario Médico
The publication specializing in medicine considers the article coordinated by Manel Esteller one of the best ideas of the year IDIBELL has received one of the awards for the Best Ideas of the Year, awarded by the publication specializing in medicine and health Diario Médico, by a study concluding that epigenetic marks are degrading over […]
Susana Jiménez Murcia: ”gambling becomes an addiction when it goes from being a hobby to a necessity”
Gambling and addiction to information and communication technologies, which are encompassed within the generic term of behavioural addictions, is an increasing health and social problem. The head of the Pathological Gambling Unit of the Bellvitge University Hospital and IDIBELL researcher Susana Jiménez-Murcia spoke on November 20 about gambling and addiction to technology at Centre Cultural […]